Estrogen alone may not fully overcome insulin resistance in the setting of obesity, while GLP-1 therapies do not directly restore the hormonal environment that supports mitochondrial and tissue-level function
The ORIGIN trial showed that insulin glargine neither increased nor decreased cardiovascular events compared to standard care
It typically requires ongoing management
Counterfeit medication: The FDA warns that counterfeit GLP-1 medicationscan containtoo much, too little, or none of their active ingredients
The FDA does not check these compounded medications for their safety, quality, or effectiveness before they are sold
Your compounded vial delivers the exact same medication, just in a different format, with the added benefit of adjustable dosing , especially useful for tailoring your plan or extending the vial based on your body's response